e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Ihre E., Gyllfors P., Gustafsson L. E., Kumlin M., Dahlen B.
Source:
Eur Respir J 2006; 27: 1152-1159
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ihre E., Gyllfors P., Gustafsson L. E., Kumlin M., Dahlen B.. Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge. Eur Respir J 2006; 27: 1152-1159
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma
Source: Eur Respir J 2001; 18: 635-639
Year: 2001
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002
Exhaled nitric oxide and lower airway involvement in persistent rhinitis
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
L-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction
Source: Eur Respir J 2009; 34: 191-199
Year: 2009
Increased nitric oxide production by neutrophils in bronchial asthma
Source: Eur Respir J 2001; 17: 868-871
Year: 2001
Ciclesonide decreases exhaled breath nitric oxide and rapidly reduces airway responsiveness to adenosine monophosphate in asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 252s
Year: 2005
The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 366s
Year: 2007
Increased exhaled nitric oxide (E-NO) in asthmatics with bronchial hyperreactivity to MCh and UNDW
Source: Eur Respir J 2001; 18: Suppl. 33, 164s
Year: 2001
Exhaled nitric oxide in asthma
Source: Eur Respir Monogr 2010; 49: 32-44
Year: 2010
Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002
Relationship between exhaled nitric oxide and bronchial hyperreactivity in adult with asthma
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009
Exhaled nitric oxide is a useful marker of airway hyperreactivity in patients with chronic cough
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005
Methacholine airway hyperresponsiveness is associated with fraction of nitric oxide irrespective of asthma
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012
Inhibitors of NADPH-oxidase or nitric oxide synthase prevent airway hyperresponsiveness but not allergic inflammation in mice
Source: Eur Respir J 2001; 18: Suppl. 33, 265s
Year: 2001
Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Nitric oxide is a poor bronchodilator but reduces release of leukotrienes in the peripheral airways
Source: Eur Respir J 2005; 26: Suppl. 49, 128s
Year: 2005
Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
Biomarkers of human asthma; the effect of inhaled AMP on exhaled nitric oxide and circulating VEGF levels
Source: Eur Respir J 2005; 26: Suppl. 49, 229s
Year: 2005
Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms
Source: Eur Respir J 2002; 20: 841-845
Year: 2002
Exhaled nitric oxide during infancy as a risk factor for asthma and airway hyperreactivity
Source: Eur Respir J 2015; 45: 98-106
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept